{
    "study_accession": "SDY31",
    "actual_completion_date": null,
    "actual_enrollment": 96,
    "actual_start_date": "2008-08-12",
    "age_unit": "Weeks",
    "brief_description": "Inbred C57BL/6 female mice (8-10 weeks old) were immunized subcutaneously according to the 8 immunization groups.  Serum samples were collected weekly from 2 staggered groups and analyzed for PA-specific (Total Ig, IgG1, IgG2a, and IgG3) and neutralizing antibody titers.  Also, spleen, thymus, and brachial and inguinal lymph nodes will be harvested from 1 of each group at 4 time points for histology.  ",
    "brief_title": "Determining the effect of different adjuvants and doses on the immune response",
    "clinical_trial": "N",
    "condition_studied": "different adjuvants and doses on the immune response to rPA",
    "dcl_id": 2,
    "description": "Inbred C57BL/6 female mice (8-10 weeks old) were immunized subcutaneously according to the 8 immunization groups.  Serum samples were collected weekly from 2 staggered groups and analyzed for PA-specific (Total Ig, IgG1, IgG2a, and IgG3) and neutralizing antibody titers.  Also, spleen, thymus, and brachial and inguinal lymph nodes will be harvested from 1 of each group at 4 time points for histology.  ",
    "doi": "10.21430/M37IXT07LU",
    "endpoints": "Mice were sacrificed at designated time points. ELISA and Immunohistochemistry assays were done on samples collected from the mice.",
    "gender_included": "Female",
    "hypothesis": null,
    "initial_data_release_date": "2014-01-17",
    "initial_data_release_version": "DR7",
    "intervention_agent": "rPA + (Alum or LPS or oCpG)\r",
    "latest_data_release_date": "2014-01-17",
    "latest_data_release_version": "DR7",
    "maximum_age": "10",
    "minimum_age": "8",
    "objectives": "To determine the effect of different adjuvants and doses on the immune response.",
    "official_title": "Determining the effect of different adjuvants and doses on the immune response",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 106,
    "workspace_id": 1885,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM343",
            "description": "Subject was injected with saline, bleed follow bleeding schedule A (bleed days: 7,22,35,49,65,72,79)",
            "name": "control_bleed_group_A"
        },
        {
            "arm_accession": "ARM344",
            "description": "Subject was injected with saline, bleed follow bleeding schedule B (bleed days  -1,15,29,43,57,65,72,79)",
            "name": "control_bleed_group_B"
        },
        {
            "arm_accession": "ARM345",
            "description": "Subject was injected with saline, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "control_Sac"
        },
        {
            "arm_accession": "ARM346",
            "description": "Subject was injected with Alum 1.3 mg, bleed follow bleeding schedule A (bleed days: 7,22,35,49,65,72,79)",
            "name": "Alum_bleed_group_A"
        },
        {
            "arm_accession": "ARM347",
            "description": "Subject was injected with Alum 1.3 mg, bleed follow bleeding schedule B (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "Alum_bleed_group_B"
        },
        {
            "arm_accession": "ARM348",
            "description": "Subject was injected with Alum 1.3 mg, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "Alum_Sac"
        },
        {
            "arm_accession": "ARM349",
            "description": "Subject was injected with LPS 10ug, bleed follow bleeding schedule A (bleed days:7,22,35,49,65,72,79)",
            "name": "LPS_10_bleed_group_A"
        },
        {
            "arm_accession": "ARM350",
            "description": "Subject was injected with LPS 10ug, bleed follow bleeding schedule B(bleed days: -1,15,29,43,57,65,72,79)",
            "name": "LPS_10_bleed_group_B"
        },
        {
            "arm_accession": "ARM351",
            "description": "Subject was injected with LPS 10ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "LPS_10_Sac"
        },
        {
            "arm_accession": "ARM352",
            "description": "Subject was injected with LPS 30ug, bleed follow bleeding schedule A  (bleed days: 7,22,35,49,65,72,79)",
            "name": "LPS_30_bleed_group_A"
        },
        {
            "arm_accession": "ARM353",
            "description": "Subject was injected with LPS 30ug, bleed follow bleeding schedule B  (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "LPS_30_bleed_group_B"
        },
        {
            "arm_accession": "ARM354",
            "description": "Subject was injected with LPS 30ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "LPS_30_Sac"
        },
        {
            "arm_accession": "ARM355",
            "description": "Subject was injected with LPS 100ug, bleed follow bleeding schedule A (bleed days (7,22,35,49,65,72,79)",
            "name": "LPS_100_bleed_group_A"
        },
        {
            "arm_accession": "ARM356",
            "description": "Subject was injected with LPS 100ug, bleed follow bleeding schedule B (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "LPS_100_bleed_group_B"
        },
        {
            "arm_accession": "ARM357",
            "description": "Subject was injected with LPS 100ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "LPS_100_Sac"
        },
        {
            "arm_accession": "ARM358",
            "description": "Subject was injected with oCpG 10ug, bleed follow bleeding schedule A (bleed days: 7,22,35,49,65,72,79)",
            "name": "oCpG_10_bleed_group_A"
        },
        {
            "arm_accession": "ARM359",
            "description": "Subject was injected with oCpG 10ug, bleed follow bleeding schedule B (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "oCpG_10_bleed_group_B"
        },
        {
            "arm_accession": "ARM360",
            "description": "Subject was injected with oCpG 10ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "oCpG_10_Sac"
        },
        {
            "arm_accession": "ARM361",
            "description": "Subject was injected with oCpG 30ug, bleed follow bleeding schedule A (bleed days: 7,22,35,49,65,72,79)",
            "name": "oCpG_30_bleed_group_A"
        },
        {
            "arm_accession": "ARM362",
            "description": "Subject was injected with oCpG 30ug, bleed follow bleeding schedule B (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "oCpG_30_bleed_group_B"
        },
        {
            "arm_accession": "ARM363",
            "description": "Subject was injected with oCpG 30ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "oCpG_30_Sac"
        },
        {
            "arm_accession": "ARM364",
            "description": "Subject was injected with oCpG 100ug, bleed follow bleeding schedule A (bleed days: 7,22,35,49,65,72,79)",
            "name": "oCpG_100_bleed_group_A"
        },
        {
            "arm_accession": "ARM365",
            "description": "Subject was injected with oCpG 100ug, bleed follow bleeding schedule B (bleed days: -1,15,29,43,57,65,72,79)",
            "name": "oCpG_100_bleed_group_B"
        },
        {
            "arm_accession": "ARM366",
            "description": "Subject was injected with oCpG 100ug, Sac at various days to collect tissues (sac days: 2,8,15,57)",
            "name": "oCpG_100_Sac"
        }
    ],
    "personnel": [
        {
            "first_name": "Thomas",
            "last_name": "Kepler",
            "organization": "Duke Human Vaccine Institute",
            "role_in_study": "Principal Investigator",
            "site_name": "Duke Human Vaccine Institute\r"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Modeling Immunity for Biodefense I",
            "contract_name": "Multiscale Systems Immunology for Adjuvant Development"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISA",
            "number_of_expsamples": 1788
        },
        {
            "measurement_technique": "Flow Cytometry",
            "number_of_expsamples": 617
        }
    ],
    "subject": {
        "race": [],
        "gender": []
    }
}
